Arch Therapeutics, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Arch Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2011 to 2023.
  • Arch Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending December 31, 2023 was $846K.
  • Arch Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $2.85M, a 2.79% decline from 2022.
  • Arch Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $2.94M, a 59.6% decline from 2021.
  • Arch Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $7.27M, a 90% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.85M -$81.9K -2.79% Oct 1, 2022 Sep 30, 2023 10-K 2024-02-15
2022 $2.94M -$4.33M -59.6% Oct 1, 2021 Sep 30, 2022 10-K 2024-02-15
2021 $7.27M +$3.44M +90% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-28
2020 $3.83M +$1.04M +37.6% Oct 1, 2019 Sep 30, 2020 10-K 2021-12-17
2019 $2.78M -$1.82M -39.6% Oct 1, 2018 Sep 30, 2019 10-K 2020-12-11
2018 $4.6M -$1.98M -30.1% Oct 1, 2017 Sep 30, 2018 10-K 2019-11-19
2017 $6.58M +$759K +13% Oct 1, 2016 Sep 30, 2017 10-K 2018-12-18
2016 $5.82M Oct 1, 2015 Sep 30, 2016 10-K 2017-11-15
2014 $3.62M +$1.65M +83.5% Oct 1, 2013 Sep 30, 2014 10-K 2014-12-12
2013 $1.97M +$1.74M +740% Oct 1, 2012 Sep 30, 2013 10-K 2014-12-12
2012 $235K +$215K +1071% Oct 1, 2011 Sep 30, 2012 10-K/A 2014-05-01
2011 $20.1K Oct 1, 2010 Sep 30, 2011 10-K 2012-12-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.